ImmunoglobulinPDF
IVIG
Intravenous immunoglobulin
ExamplesPrivigen, Gamunex-C, Gammagard, Panzyga
Clinical documentation checklist
- Specialist note identifying the exact diagnosis, severity, treatment goal and requested product.
- For antibody deficiency: pretreatment IgG/IgA/IgM, vaccine-response results and infection history, as applicable.
- For neurologic / other indications: diagnosis-specific testing, functional scores and prior treatment outcomes.
- Previous IG product, regimen, tolerance and dated weight; any product-specific supporting records.
- Renewal: objective response, infection frequency or functional change, current dose and continued need.
Documentation prompts, not universal criteria. Match the exact indication, product and member’s plan. Example payer policy ↗
ImmunoglobulinPDF
SCIG
Subcutaneous immunoglobulin
ExamplesHizentra, Cuvitru, Xembify, HyQvia
Clinical documentation checklist
- Diagnosis and specialist assessment supporting the requested SCIG product and indication.
- For antibody deficiency: pretreatment immunoglobulins, antibody response and infection history, as applicable.
- For other indications: diagnostic evidence and prior therapy records required by the exact product / plan.
- Current IG dose, dates, response and reason for change; administration / training plan and dated weight.
- Renewal: infection or functional outcomes, adherence, tolerance and continuing clinical need.
Documentation prompts, not universal criteria. Match the exact indication, product and member’s plan. Example payer policy ↗
Rare disease & otherPDF
Alpha-1 augmentation
Alpha-1 proteinase inhibitor
ExamplesProlastin-C, Glassia, Zemaira, Aralast NP
Clinical documentation checklist
- Specialist documentation of AAT deficiency and relevant lung disease; exact augmentation product.
- Pretreatment serum alpha-1 antitrypsin level with units and lab method, plus phenotype / genotype.
- Pulmonary function report including post-bronchodilator FEV1; supporting imaging when requested.
- Dated weight, previous augmentation regimen and smoking history / cessation documentation as applicable.
- Renewal: documented clinical benefit, adherence, tolerance and current treatment plan.
Documentation prompts, not universal criteria. Match the exact indication, product and member’s plan. Example payer policy ↗
Autoimmune & GIPDF
Infliximab
Infliximab products
ExamplesRemicade, Inflectra, Renflexis, Avsola, Zymfentra
Clinical documentation checklist
- Diagnosis-specific specialist notes: disease activity, severity and relevant examination findings.
- Objective evidence for the indication: GI studies, joint assessments or skin involvement, as applicable.
- Prior conventional / biologic treatments: drug, dose, dates, outcome, intolerance or contraindication.
- Exact product / route, induction history, current weight and clinician-required screening records.
- Renewal: documented response; clinical rationale and supporting records for any dose / interval change.
Documentation prompts, not universal criteria. Match the exact indication, product and member’s plan. Example payer policy ↗
Autoimmune & GIPDF
Vedolizumab
Vedolizumab
ExamplesEntyvio
Clinical documentation checklist
- Gastroenterology notes with diagnosis, activity, symptoms and clinical reason for therapy.
- Available endoscopy / pathology, imaging and inflammatory markers supporting the GI diagnosis.
- Prior treatments and response, dated trials, intolerance / contraindication, and steroid dependence if relevant.
- Exact IV or SC formulation, induction dates and maintenance plan; current therapy / screening records.
- Renewal: symptom / objective improvement, steroid use and rationale for continued treatment.
Documentation prompts, not universal criteria. Match the exact indication, product and member’s plan. Example payer policy ↗
Autoimmune & GIPDF
Ustekinumab
Ustekinumab products
ExamplesStelara and biosimilars
Clinical documentation checklist
- Specialist note identifying the indication, severity and exact requested product / formulation.
- GI: diagnostic studies and activity; skin: body areas / severity; joint disease: clinical activity, as applicable.
- Previous therapies with doses, dates, outcomes and reasons preferred alternatives are unsuitable.
- Induction versus maintenance history, dated weight and clinician-required pretreatment screening.
- Renewal: improvement in the relevant disease measures and continued need for the prescribed regimen.
Documentation prompts, not universal criteria. Match the exact indication, product and member’s plan. Example payer policy ↗
Autoimmune & GIPDF
Risankizumab
Risankizumab-rzaa
ExamplesSkyrizi
Clinical documentation checklist
- Specialist diagnosis, disease activity and exact indication for the requested formulation.
- GI studies, skin severity / affected areas, or joint findings relevant to the patient's indication.
- Prior systemic / biologic treatments with dates, response, intolerance or contraindication.
- Induction and maintenance plan; screening and monitoring documentation required for the indication.
- Renewal: objective or symptom response, current regimen and explanation of requested changes.
Documentation prompts, not universal criteria. Match the exact indication, product and member’s plan. Example payer policy ↗
Autoimmune & GIPDF
Abatacept
Abatacept
ExamplesOrencia
Clinical documentation checklist
- Rheumatology / relevant specialist assessment documenting diagnosis, activity and clinical severity.
- Indication-specific objective support: joint findings, disease activity measures and diagnostic labs.
- Previous DMARD / biologic trials with dose, dates, response and contraindications or intolerance.
- Exact IV or SC formulation, current weight if relevant, concomitant medications and required screening.
- Renewal: documented disease improvement, tolerability and continuing treatment plan.
Documentation prompts, not universal criteria. Match the exact indication, product and member’s plan. Example payer policy ↗
Autoimmune & GIPDF
Tocilizumab
Tocilizumab products
ExamplesActemra and biosimilars
Clinical documentation checklist
- Specialist notes specifying the exact indication and severity; requested product and route.
- Indication-specific diagnostic evidence and baseline disease activity / inflammatory findings.
- Previous therapies, adequate trial dates and outcomes; reasons alternatives are inappropriate.
- Prescriber-directed screening / monitoring records, such as TB, blood counts and liver tests, as applicable.
- Renewal: clinical response, current regimen, concomitant therapies and relevant monitoring results.
Documentation prompts, not universal criteria. Match the exact indication, product and member’s plan. Example payer policy ↗
Autoimmune & GIPDF
Rituximab
Rituximab products
ExamplesRituxan, Ruxience, Truxima, Riabni
Clinical documentation checklist
- Specialist notes confirming the exact indication, clinical severity and requested product.
- Indication-specific diagnostic reports and baseline disease measures supporting medical necessity.
- Previous treatments, dose / duration / response; previous rituximab courses and reason for retreatment.
- Clinician-required screening, including hepatitis B records where applicable, and prescribed monitoring.
- Renewal: objective treatment response, course dates, tolerance and rationale for another course.
Documentation prompts, not universal criteria. Match the exact indication, product and member’s plan. Example payer policy ↗
Autoimmune & GIPDF
Belimumab
Belimumab
ExamplesBenlysta
Clinical documentation checklist
- Specialist confirmation of the lupus indication, activity and relevant organ involvement.
- Autoantibody results and disease activity documentation; renal studies for nephritis when applicable.
- Current standard therapy and prior treatment trials, with dates, response or contraindication.
- Requested IV or SC product, clinical reason for therapy and prescriber-required safety records.
- Renewal: improvement in lupus activity / relevant organ measures and continuing standard therapy.
Documentation prompts, not universal criteria. Match the exact indication, product and member’s plan. Example payer policy ↗
Autoimmune & GIPDF
Anifrolumab
Anifrolumab-fnia
ExamplesSaphnelo
Clinical documentation checklist
- Rheumatology assessment documenting active SLE, severity and organ involvement.
- Autoantibody / diagnostic results and a baseline disease activity assessment, as required by the plan.
- Current standard lupus therapy and prior trials with response, intolerance or contraindications.
- Exact formulation; relevant infection / safety assessment and concomitant medication record.
- Renewal: change in disease activity, symptoms or steroid use and documented continued clinical benefit.
Documentation prompts, not universal criteria. Match the exact indication, product and member’s plan. Example payer policy ↗
Autoimmune & GIPDF
Golimumab
Golimumab
ExamplesSimponi, Simponi Aria
Clinical documentation checklist
- Specialist diagnosis and severity; specify Simponi versus Simponi Aria and the intended route.
- Disease-specific evidence, such as joint findings, diagnostic labs or GI studies, as applicable.
- Prior DMARD / biologic trials and concomitant therapy; dose, duration, outcomes and contraindications.
- Prescriber-required screening and dated weight when relevant; initial versus maintenance regimen.
- Renewal: clinical response, tolerance and rationale for ongoing therapy or regimen changes.
Documentation prompts, not universal criteria. Match the exact indication, product and member’s plan. Example payer policy ↗
NeurologyPDF
Ocrelizumab
Ocrelizumab-based products
ExamplesOcrevus, Ocrevus Zunovo
Clinical documentation checklist
- Neurologist assessment specifying MS subtype, course and relevant functional / relapse history.
- Diagnostic records, including MRI findings and other support for the MS diagnosis when requested.
- Prior disease-modifying therapies, dates, response and reasons for discontinuation / transition.
- Exact formulation, last treatment date and clinician-required screening / vaccination documentation.
- Renewal: disease activity / functional change, current treatment response and medication reconciliation.
Documentation prompts, not universal criteria. Match the exact indication, product and member’s plan. Example payer policy ↗
NeurologyPDF
Natalizumab
Natalizumab products
ExamplesTysabri, Tyruko
Clinical documentation checklist
- Specialist note specifying the indication, disease activity and exact natalizumab product.
- Indication-specific diagnostics (MS or GI), prior therapies and documented response / intolerance.
- Applicable product program / REMS enrollment documentation and authorized administration arrangements.
- Prescriber risk assessment and monitoring records, including JCV-related records when applicable.
- Renewal: response, treatment dates, concomitant medication review and current program requirements.
Documentation prompts, not universal criteria. Match the exact indication, product and member’s plan. Example payer policy ↗
NeurologyPDF
Efgartigimod
Efgartigimod-based products
ExamplesVyvgart, Vyvgart Hytrulo
Clinical documentation checklist
- Neurologist diagnosis, exact product / route and the indication-specific treatment rationale.
- gMG: baseline severity / MG-ADL and antibody records as requested; verify current product / plan criteria.
- CIDP, when applicable: diagnostic / electrodiagnostic support and baseline functional measures.
- Previous therapies with dates / outcomes, current regimen and clinician-directed safety records.
- Renewal: comparable symptom / functional scores, response by cycle and rationale for continued use.
Documentation prompts, not universal criteria. Match the exact indication, product and member’s plan. Example payer policy ↗
Rare disease & otherPDF
Ravulizumab
Ravulizumab-cwvz
ExamplesUltomiris
Clinical documentation checklist
- Specialist note identifying the exact indication, severity and reason for complement-inhibitor treatment.
- Indication-specific support: PNH flow cytometry / hemolysis; aHUS workup; or relevant neurologic antibodies.
- Previous treatments, current weight, last complement-inhibitor dose and transition / maintenance plan.
- Applicable REMS / enrollment, meningococcal vaccination and prescriber-directed prevention records.
- Renewal: indication-specific response (labs, organ function or clinical scores) and continued need.
Documentation prompts, not universal criteria. Match the exact indication, product and member’s plan. Example payer policy ↗
Rare disease & otherPDF
Eculizumab
Eculizumab products
ExamplesSoliris and biosimilars
Clinical documentation checklist
- Specialist diagnosis, exact product and documented disease severity / medical necessity.
- Diagnosis-specific evidence: PNH testing; aHUS workup; or neurologic diagnostic / antibody records.
- Previous therapies with dated outcomes, current weight and prior complement-inhibitor treatment.
- Applicable product REMS / enrollment, meningococcal vaccination and prevention documentation.
- Renewal: objective response, current dosing history and ongoing clinical need for the exact product.
Documentation prompts, not universal criteria. Match the exact indication, product and member’s plan. Example payer policy ↗
NeurologyPDF
Edaravone
Edaravone products
ExamplesEdaravone injection, Radicava ORS
Clinical documentation checklist
- ALS specialist / neurologist assessment and diagnostic evidence supporting definite or probable ALS.
- Baseline ALSFRS-R with dated item scores; respiratory / ventilatory status and requested supporting tests.
- Clinical history and prior / current ALS treatments with dates, response and tolerance.
- Exact formulation and route; prescribed cycle, last treatment dates and administration needs.
- Renewal: clinical benefit, functional / respiratory status and continuing plan; verify route-specific policy.
Documentation prompts, not universal criteria. Match the exact indication, product and member’s plan. Example payer policy ↗
NeurologyPDF
Eptinezumab
Eptinezumab-jjmr
ExamplesVyepti
Clinical documentation checklist
- Migraine diagnosis with baseline headache days and migraine days per month, supported by dated records.
- Prior preventive medicines: dose, trial duration, response, intolerance or contraindication.
- Current preventive and acute medications; prior CGRP / botulinum therapy and transition plan if relevant.
- Prescriber assessment of functional burden and reason for requested product / regimen.
- Renewal: change in migraine frequency or severity and documented benefit compared with baseline.
Documentation prompts, not universal criteria. Match the exact indication, product and member’s plan. Example payer policy ↗
Rare disease & otherPDF
Teprotumumab
Teprotumumab-trbw
ExamplesTepezza
Clinical documentation checklist
- Specialist TED diagnosis and activity / severity assessment; document chronic or active disease.
- Eye findings: proptosis, diplopia, soft-tissue changes or clinical activity score, as applicable.
- Thyroid function / management and prior TED treatments; number and dates of previous infusions.
- Prescriber-directed baseline / monitoring records, including hearing and glucose assessment as applicable.
- Continuation: treatment response and planned remaining course; verify payer lifetime / retreatment limits.
Documentation prompts, not universal criteria. Match the exact indication, product and member’s plan. Example payer policy ↗
Autoimmune & GIPDF
Pegloticase
Pegloticase
ExamplesKrystexxa
Clinical documentation checklist
- Chronic refractory gout diagnosis with flares, tophi or gout-related joint damage documented.
- Dated serum urate results and prior urate-lowering trials with doses, duration and response / intolerance.
- Prescriber safety records, including G6PD status where applicable, and planned monitoring.
- Concomitant immunomodulator plan or clinical reason for omission; previous pegloticase dates.
- Renewal: serum urate trend, clinical response, tolerance and continued treatment rationale.
Documentation prompts, not universal criteria. Match the exact indication, product and member’s plan. Example payer policy ↗
Allergy & asthmaPDF
Omalizumab
Omalizumab
ExamplesXolair
Clinical documentation checklist
- Specialist diagnosis and indication-specific severity; verify the exact product / formulation.
- For asthma / polyps / food allergy: IgE, weight and diagnostic testing as applicable to the indication.
- For urticaria: symptom duration / severity and prior antihistamine trials; other indications use their criteria.
- Prior / current therapies, dates and outcomes; exacerbation history or allergic-event history as relevant.
- Renewal: indication-specific improvement, adherence and continued need; administration plan documented.
Documentation prompts, not universal criteria. Match the exact indication, product and member’s plan. Example payer policy ↗
Allergy & asthmaPDF
Dupilumab
Dupilumab
ExamplesDupixent
Clinical documentation checklist
- Specialist documentation of the exact indication, severity and requested device / formulation.
- For dermatitis: affected body areas, severity / functional burden and prior topical / systemic treatments.
- For other indications: obtain the current payer criteria and diagnosis-specific studies / clinical measures.
- Previous therapy doses, durations, response and reasons alternatives are unsuitable; current therapy list.
- Renewal: indication-specific improvement and continued need; dose and device match the patient / order.
Documentation prompts, not universal criteria. Match the exact indication, product and member’s plan. Example payer policy ↗
Allergy & asthmaPDF
Mepolizumab
Mepolizumab
ExamplesNucala
Clinical documentation checklist
- Specialist diagnosis and severity; specify the indication and exact product / device.
- For eosinophilic asthma: dated eosinophil counts, exacerbations, steroid use and controller regimen.
- For other indications: diagnosis-specific evidence (e.g., nasal findings, EGPA / HES workup) per payer policy.
- Previous therapies, doses, dates and outcomes; current medications and required exclusion workup.
- Renewal: clinical improvement, exacerbation / steroid trend or other indication-specific response.
Documentation prompts, not universal criteria. Match the exact indication, product and member’s plan. Example payer policy ↗